Home Category Region Publishers About Us Contact Us
Home > Market Research Report > Medical Device > Catheter Equipment > Japanese Markets for Peripheral Vascular Devices 2010
Category
Medical Device (4399)
Cardiovascular Device (252)
Catheter Equipment (209)
CT and MRI and X ray (146)
Dental Equipment (177)
Disposable Medical Device (83)
Endoscopy Equipment (114)
Healthcare IT (310)
In Vitro Diagnostics Equipment (436)
Medical Imaging (425)
Molecular Imaging/Agents (29)
Nuclear Medical (76)
Ophthalmic Equipment (105)
Orthopedic (343)
Patient Monitoring (384)
Ultra Sound (50)
Wound Care (120)
Market Research Report

Japanese Markets for Peripheral Vascular Devices 2010

Published by Millennium Research Group
Published December, 2009 Product code 106615
Content info  
Price
Not Available

This publication has been discontinued on July 21, 2011.

Below is the updated product.

Published: July, 2011
Product code: 196266

Introduction

Abstract

Through 2014, the Japanese peripheral vascular (PV) device market will grow at a steady compound annual growth rate as a result of a rapidly aging population - more prone to peripheral vascular disease (PVD) - and new device approvals, especially in the PV stent, embolic protection device (EPD), and aortic stent graft segments. The strict regulatory environment in Japan has often impeded competitors trying to enter this market, but progress is being made toward improving the efficiency of the regulatory process, resulting in more device approvals in recent years. These new device approvals will drive adoption of minimally invasive procedures by increasing disease awareness and availability of endovascular treatments. Moreover, Japan has one of the fastest growing elderly populations in the world, which is putting a strain on the Japanese health care system. In response, the Japanese government will look toward implementing more drastic reimbursement cuts than have been seen in previous years. These reimbursement cuts will limit revenues in this market somewhat through 2014. Nevertheless, a growing number of physicians outside the interventional radiology space are adopting minimally invasive treatments for PVD, which will increase diagnosis rates and patient access to endovascular treatments. This will in turn lead to climbing procedure volumes and expanding revenues over the forecast period.

Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

  • Government Sources:
    • Securities and Exchange Commission filings
    • Food and Drug Administration and patent filings
    • National Center for Health Statistics data
  • Peripheral Vascular (PV) Device Companies:
    • Annual reports, product brochures, corporate profiles, etc.
  • Internal Databases and Reports:
    • Previous reports on similar/related sources
  • General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
    • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various PV device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Forecast Methodology

In addition to Steps 1 through 4 (as outlined above), the following “bottom-up” methodology was followed in developing forecast assumptions for this report. A comprehensive breakdown of various PV procedures was prepared using data from several sources including professional associations, government statistics, and private research/media sources. Industry experts and practitioners were consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through 10-Ks and other sources were compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and in-house experts, year-by-year growth rates and average selling prices were applied individually to each subcategory to derive forecasts. These estimates were cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings were compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 PERIPHERAL VASCULAR DISEASE OVERVIEW

  • 1.1 Disease Overview
  • 1.2 Device Overview
    • 1.2.1 Peripheral Vascular Stents
    • 1.2.2 PTA Balloon Catheters
    • 1.2.3 Embolic Protection Devices
    • 1.2.4 Inferior Vena Cava Filters
    • 1.2.5 Aortic Stent Grafts
    • 1.2.6 Synthetic Surgical Grafts
    • 1.2.7 Accessory Devices
  • 1.3 Indication Overview
    • 1.3.1 Carotid Artery
    • 1.3.2 Renal Artery
    • 1.3.3 Iliac Artery
    • 1.3.4 Lower-Extremity: Femoropopliteal and Infrapopliteal Arteries
    • 1.3.5 Aorta
      • 1.3.5.1 Abdominal Aorta
      • 1.3.5.2 Thoracic Aorta
    • 1.3.6 Arteriovenous Access
    • 1.3.7 Inferior Vena Cava

2.0 JAPANESE PERIPHERAL VASCULAR DEVICE MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Key Report Updates
    • 2.2.2 Economic Assumptions in the Forecast Period
    • 2.2.3 Japanese Medical Device Approval
    • 2.2.4 Procedures
    • 2.2.5 Market Forecast
    • 2.2.6 Market Drivers and Limiters
  • 2.3 Competitive Analysis
    • 2.3.1 Market Shares

3.0 PERIPHERAL VASCULAR STENT MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Procedures by Indication
      • 3.2.1.1 Carotid Artery Stenting
      • 3.2.1.2 Renal Artery Stenting
      • 3.2.1.3 Iliac Artery Stenting
      • 3.2.1.4 Femoropopliteal Stenting
      • 3.2.1.5 Infrapopliteal Stenting
    • 3.2.2 Procedures by Stent Type
    • 3.2.3 Market Forecast by Stent Type
      • 3.2.3.1 Self-Expandable Stent Market
      • 3.2.3.2 Balloon-Expandable Stent Market
    • 3.2.4 Market Forecast by Indication
    • 3.2.5 Market Drivers and Limiters
  • 3.3 Competitive Analysis
    • 3.3.1 Competitive Landscape
    • 3.3.2 Market Shares

4.0 PTA BALLOON CATHETER MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Procedures by Type
    • 4.2.2 Procedures by Indication
      • 4.2.2.1 Carotid Artery PTAs
      • 4.2.2.2 Renal Artery PTAs
      • 4.2.2.3 Iliac Artery PTAs
      • 4.2.2.4 Femoropopliteal PTAs
      • 4.2.2.5 Infrapopliteal PTAs
      • 4.2.2.6 Arteriovenous Access PTAs
    • 4.2.3 Market Forecast by PTA Balloon Catheter Type
      • 4.2.3.1 Standard PTA Balloon Catheter Market
      • 4.2.3.2 Small PTA Balloon Catheter Market
      • 4.2.3.3 Other PTA Balloon Catheter Market
        • Large PTA Balloon Catheter Market (Qualitative Discussion)
        • High-Pressure PTA Balloon Catheter Market (Qualitative Discussion)
        • Specialty PTA Balloon Catheter Market (Qualitative Discussion)
    • 4.2.4 Market Drivers and Limiters
  • 4.3 Competitive Analysis
    • 4.3.1 Competitive Landscape
    • 4.3.2 Market Shares

5.0 EMBOLIC PROTECTION DEVICE MARKET

  • 5.1 Market Overview
  • 5.2 Market Analysis
    • 5.2.1 Procedures
    • 5.2.2 Market Forecast
    • 5.2.3 Market Drivers and Limiters
  • 5.3 Competitive Analysis
    • 5.3.1 Competitive Landscape
    • 5.3.2 Market Shares

6.0 INFERIOR VENA CAVA FILTER MARKET

  • 6.1 Market Overview
  • 6.2 Market Analysis
    • 6.2.1 Procedures
    • 6.2.2 Market Forecast
    • 6.2.3 Market Drivers and Limiters
  • 6.3 Competitive Analysis
    • 6.3.1 Competitive Landscape
    • 6.3.2 Market Shares

7.0 AORTIC STENT GRAFT MARKET

  • 7.1 Market Overview
  • 7.2 Market Analysis
    • 7.2.1 Procedures
      • 7.2.1.1 Abdominal Aortic Procedures
      • 7.2.1.2 Thoracic Aortic Procedures
    • 7.2.2 Market Forecast
      • 7.2.2.1 Abdominal Aortic Stent Graft Market
      • 7.2.2.2 Thoracic Aortic Stent Graft Market
    • 7.2.3 Market Drivers and Limiters
  • 7.3 Competitive Analysis
    • 7.3.1 Competitive Landscape
    • 7.3.2 Market Shares

8.0 SYNTHETIC SURGICAL GRAFT MARKET

  • 8.1 Market Overview
  • 8.2 Market Analysis
    • 8.2.1 Procedures by Indication
      • 8.2.1.1 Abdominal Aortic Surgical Graft Procedures
      • 8.2.1.2 Thoracic Aortic Surgical Graft Procedures
      • 8.2.1.3 Aorto-Iliac Bypass Procedures
      • 8.2.1.4 Extra-Anatomical Bypass Procedures
      • 8.2.1.5 Peripheral Bypass Procedures
        • Above-the-Knee Procedures
        • Below-the-Knee Procedures
      • 8.2.1.6 Arteriovenous Access Procedures
    • 8.2.2 Market Forecast by Graft Material
    • 8.2.3 Market Forecast by Indication
      • 8.2.3.1 Abdominal Aortic Surgical Graft Market
      • 8.2.3.2 Thoracic Aortic Surgical Graft Market
      • 8.2.3.3 Aorto-Iliac Bypass Surgical Graft Market
      • 8.2.3.4 Extra-Anatomical Bypass Surgical Graft Market
      • 8.2.3.5 Peripheral Bypass Surgical Graft Market
      • 8.2.3.6 Arteriovenous Access Surgical Graft Market
    • 8.2.4 Market Drivers and Limiters
  • 8.3 Competitive Analysis
    • 8.3.1 Competitive Landscape
    • 8.3.2 Market Shares

9.0 PERIPHERAL VASCULAR ACCESSORY DEVICE MARKET

  • 9.1 Market Overview
  • 9.2 Market Analysis
    • 9.2.1 Procedures
    • 9.2.2 Accessory Device Overview
      • 9.2.2.1 Guidewires
      • 9.2.2.2 Sheaths
      • 9.2.2.3 Diagnostic Catheters
      • 9.2.2.4 Guiding Catheters
    • 9.2.3 Market Forecast
      • 9.2.3.1 Guidewire Market
      • 9.2.3.2 Sheath Market
      • 9.2.3.3 Diagnostic Catheter Market
      • 9.2.3.4 Guiding Catheter Market
    • 9.2.4 Market Drivers and Limiters
  • 9.3 Competitive Analysis
    • 9.3.1 Competitive Landscape
    • 9.3.2 Market Shares

10.0 PERIPHERAL VASCULAR DEVICE MARKET COMPETITIVE ANALYSIS

  • 10.1 Competitive Landscape
  • 10.2 Market Shares
  • 10.3 Competitor Discussions (in Alphabetical Order)
    • Abbott Vascular
    • ALN
    • AngioScore
    • ASAHI INTECC
    • Atrium Medical
    • B. Braun
    • Boston Scientific
    • CATHEX
    • Cook Medical
    • Cordis
    • C. R. Bard
    • Endologix
    • ev3
    • Hanaco Medical
    • Invatec
    • Japan Lifeline
    • Kaneka Medix
    • MAQUET
    • Medtronic
    • Terumo Medical
    • Thoratec
    • Tokai Medical Products
    • Toray Medical
    • W. L. Gore
    • Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

  • EXECUTIVE SUMMARY
  • Exhibit 1: PV Device Market, Japan (US$), 2008 - 2014
  • Exhibit 2: PV Stent Market, Japan (US$), 2008 - 2014
  • Exhibit 3: PTA Balloon Catheter Procedures, by Type, Japan, 2008 - 2014
  • Exhibit 4: CAS Procedures and EPD Penetration, Japan, 2008 - 2014
  • Exhibit 5: IVCF Procedures, by Device Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 6: Aortic Stent Graft Market, by Indication, Japan (US$), 2008 - 2014
  • Exhibit 7: Synthetic Surgical Graft Market, by Indication, Japan (US$), 2008 - 2014
  • Exhibit 8: PV Accessory Device Market, by Type, Japan (US$), 2008 - 2014
  • Exhibit 9: Leading Competitors in the PV Device Market, Japan, 2009
  • METHODOLOGY
  • Exhibit 10: Currency Exchange Rates, 2009
  • CHAPTER 1: PERIPHERAL VASCULAR DISEASE OVERVIEW
  • Exhibit 11: EPD Descriptions, by Device Type
  • Exhibit 12: EPD Descriptions, by Device Type (Cont' d)
  • CHAPTER 2: JAPANESE PERIPHERAL VASCULAR DEVICE MARKET
  • Exhibit 13: PV Device Market, Japan (US$), 2008 - 2014
  • Exhibit 14: Key Report Updates, 2010
  • Exhibit 15: PV Procedures, by Type, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 16: PV Procedures, by Type, Japan, 2008 - 2014 (Tabular Format)
  • Exhibit 17: PV Device Market, by Device Type, as a % of Total, Japan, 2009
  • Exhibit 18: PV Device Market, by Device Type, Japan (US$), 2008 - 2014
  • Exhibit 19: PV Device Market, by Device Type, Japan (¥), 2008 - 2014
  • Exhibit 20: PV Device Market, by Device Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 21: Drivers of the PV Device Market, Japan
  • Exhibit 22: Limiters of the PV Device Market, Japan
  • Exhibit 23: Leading Competitors in the PV Device Market, as a % of Total, Japan, 2009
  • Exhibit 24: Leading Competitors in the PV Device Market, by Segment, as a % of Total, Japan, 2009
  • CHAPTER 3: PERIPHERAL VASCULAR STENT MARKET
  • Exhibit 25: PV Stent Market, Japan (US$), 2008 - 2014
  • Exhibit 26: PV Stent Procedures, by Indication, Japan, 2008 - 2014
  • Exhibit 27: PV Stent Procedures and Units, by Indication, Japan, 2008 - 2014
  • Exhibit 28: PV Stent Procedure and Unit Growth, by Indication, Japan, 2009 - 2014
  • Exhibit 29: PV Stent Procedures and Units, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 30: CREST Clinical Trial Summary, 2009
  • Exhibit 31: CORAL Clinical Trial Summary, 2009
  • Exhibit 32: ZILVER PTX Drug-Eluting Stent Clinical Trial Summary, 2009
  • Exhibit 33: PV Stent Units, by Indication and Stent Type, Japan, 2009
  • Exhibit 34: PV Stent Units, by Indication and Stent Type, as a % of Total, Japan, 2009
  • Exhibit 35: PV Stent Procedures and Units, by Stent Type, Japan, 2008 - 2014
  • Exhibit 36: PV Stent Procedure and Unit Growth, by Stent Type, Japan, 2009 - 2014
  • Exhibit 37: PV Stent Procedures and Units, by Stent Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 38: PV Stent Market, by Stent Type, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 39: PV Stent Market, by Stent Type, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 40: PV Stent Market, by Stent Type, Japan (¥), 2008 - 2014
  • Exhibit 41: PV Stent Market Growth, by Stent Type, Japan, 2009 - 2014
  • Exhibit 42: PV Stent Market, by Stent Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 43: PV Stent Market, by Indication, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 44: PV Stent Market, by Indication, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 45: PV Stent Market, by Indication, Japan (¥), 2008 - 2014
  • Exhibit 46: PV Stent Market Growth, by Indication, Japan, 2008 - 2014
  • Exhibit 47: PV Stent Market, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 48: Drivers of the PV Stent Market, Japan
  • Exhibit 49: Limiters of the PV Stent Market, Japan
  • Exhibit 50: Leading Competitors in the PV Stent Market, by Indication, as a % of Total, Japan, 2009
  • CHAPTER 4: PTA BALLOON CATHETER MARKET
  • Exhibit 51: PTA Balloon Catheter Market, Japan (US$), 2008 - 2014
  • Exhibit 52: PTA Balloon Catheter Procedures, by Procedure Type, Japan, 2008 - 2014
  • Exhibit 53: PTA Balloon Catheter Procedures, by Procedure Type and Indication, Japan, 2009
  • Exhibit 54: PTA Balloon Catheter Procedures, by Procedure Type and Indication, as a % of Total, Japan, 2009
  • Exhibit 55: POBAs, by Indication, Japan, 2008 - 2014
  • Exhibit 56: POBAs, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 57: PTA-with-Stent Procedures, by Indication, Japan, 2008 - 2014
  • Exhibit 58: PTA-with-Stent Procedures, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 59: PTA Balloon Catheter Procedures, by Indication, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 60: PTA Balloon Catheter Procedures, by Indication, as a % of Total, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 61: PTA Balloon Catheter Procedures, by Indication, Japan, 2008 - 2014 (Tabular Format)
  • Exhibit 62: PTA Balloon Catheter Procedures, by Indication, as a % Total, Japan, 2008 - 2014 (Tabular Format)
  • Exhibit 63: Primary Indications for PTA Balloon Catheter Market, by Device Type
  • Exhibit 64: PTA Balloon Catheter Market, by Device Type, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 65: PTA Balloon Catheter Market, by Device Type, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 66: PTA Balloon Catheter Market, by Device Type, Japan (¥), 2008 - 2014
  • Exhibit 67: PTA Balloon Catheter Market Growth, by Device Type, Japan, 2009 - 2014
  • Exhibit 68: PTA Balloon Catheter Market, by Device Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 69: Drivers of the PTA Balloon Catheter Market, Japan
  • Exhibit 70: Limiters of the PTA Balloon Catheter Market, Japan
  • Exhibit 71: Leading Competitors in the PTA Balloon Catheter Market, by Device Type, as a % of Total, Japan, 2009
  • CHAPTER 5: EMBOLIC PROTECTION DEVICE MARKET
  • Exhibit 72: EPD Market, Japan (US$), 2008 - 2014
  • Exhibit 73: CAS Procedures and EPD Penetration, Japan, 2008 - 2014
  • Exhibit 74: CAS and EPD Procedures, Japan, 2008 - 2014
  • Exhibit 75: EPD Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 76: Drivers of the EPD Market, Japan
  • Exhibit 77: Limiters of the EPD Market, Japan
  • Exhibit 78: Leading Competitors in the EPD Market, as a % of Total, Japan, 2009
  • CHAPTER 6: INFERIOR VENA CAVA FILTER MARKET
  • Exhibit 79: IVCF Market, Japan (US$), 2008 - 2014
  • Exhibit 80: IVCF Placement Procedures, by Device Type, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 81: IVCF Placement Procedures, by Device Type, Japan, 2008-2014 (Tabular Format)
  • Exhibit 82: IVCF Market, by Device Type, as a % of Total, Japan, 2009 and 2014
  • Exhibit 83: IVCF Market, by Device Type, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 84: IVCF Market Growth, by Device Type, Japan, 2009 - 2014
  • Exhibit 85: IVCF Market, by Device Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 86: Drivers of the IVCF Market, Japan
  • Exhibit 87: Limiters of the IVCF Market, Japan
  • Exhibit 88: Leading Competitors in the IVCF Market, by Device Type, as a % of Total, Japan, 2009
  • CHAPTER 7: AORTIC STENT GRAFT MARKET
  • Exhibit 89: Aortic Stent Graft Market, Japan (US$), 2008 - 2014
  • Exhibit 90: Aortic Stent Graft Procedures, by Indication, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 91: Aortic Stent Graft Procedures, by Indication, Japan, 2008 - 2014 (Tabular Format)
  • Exhibit 92: Abdominal Aortic Procedures, by Type, Japan, 2008 - 2014
  • Exhibit 93: Thoracic Aortic Procedures, by Type, Japan, 2008 - 2014
  • Exhibit 94: Aortic Stent Graft Market, by Indication, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 95: Aortic Stent Graft Market, by Indication, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 96: Aortic Stent Graft Market, by Indication, Japan (¥), 2008 - 2014
  • Exhibit 97: Aortic Stent Graft Market Growth, by Indication, Japan, 2009 - 2014
  • Exhibit 98: Aortic Stent Graft Market, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 99: Drivers of the Aortic Stent Graft Market, Japan
  • Exhibit 100: Limiters of the Aortic Stent Graft Market, Japan
  • Exhibit 101: Leading Competitors in the Aortic Stent Graft Market, as a % of Total, Japan 2009
  • CHAPTER 8: SYNTHETIC SURGICAL GRAFT MARKET
  • Exhibit 102: Synthetic Surgical Graft Market, Japan (US$), 2008 - 2014
  • Exhibit 103: Synthetic Surgical Graft Procedures and Growth, by Indication, Japan, 2008 - 2014
  • Exhibit 104: Synthetic Surgical Graft Procedures, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 105: Synthetic Surgical Graft Market, by Graft Material, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 106: Synthetic Surgical Graft Market, by Graft Material, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 107: Synthetic Surgical Graft Market, by Graft Material, Japan (¥), 2008 - 2014
  • Exhibit 108: Synthetic Surgical Graft Market Growth, by Graft Material, Japan, 2009 - 2014
  • Exhibit 109: Synthetic Surgical Graft Market, by Graft Material, as a % of Total, Japan, 2008 - 2014
  • Exhibit 110: Synthetic Surgical Graft Market, by Indication, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 111: Synthetic Surgical Graft Market, by Indication, Japan (US$), 2008 - 2014 (Tabular Format)
  • Exhibit 112: Synthetic Surgical Graft Market, by Indication, Japan (¥), 2008 - 2014
  • Exhibit 113: Synthetic Surgical Graft Market, by Indication, as a % of Total, Japan, 2008 - 2014
  • Exhibit 114: Abdominal Aortic Surgical Graft Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 115: Thoracic Aortic Surgical Graft Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 116: Aorto-Iliac Bypass Surgical Graft Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 117: Extra-Anatomical Bypass Surgical Graft Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 118: Peripheral Bypass Surgical Graft Market, by Indication, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 119: Peripheral Bypass Surgical Graft Market Growth, by Indication, Japan, 2009 - 2014
  • Exhibit 120: AV Access Surgical Graft Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 121: Drivers of the Synthetic Surgical Graft Market, Japan
  • Exhibit 122: Limiters of the Synthetic Surgical Graft Market, Japan
  • Exhibit 123: Leading Competitors in the Synthetic Surgical Graft Market, by Graft Material, as a % of Total, Japan, 2009
  • CHAPTER 9: PERIPHERAL VASCULAR ACCESSORY DEVICE MARKET
  • Exhibit 124: PV Accessory Device Market, Japan (US$), 2008 - 2014
  • Exhibit 125: Peripheral Interventional and Diagnostic Procedures, by Type, Japan, 2008 - 2014 (Graphical Format)
  • Exhibit 126: Peripheral Interventional and Diagnostic Procedures, by Type, Japan, 2008 - 2014 (Tabular Format)
  • Exhibit 127: PV Accessory Device Units, by Device Type, Japan, 2008 - 2014
  • Exhibit 128: PV Accessory Device Market, by Device Type, Japan (US$), 2008 - 2014 (Graphical Format)
  • Exhibit 129: PV Accessory Device Market, by Device Type, Japan (US$ and ¥), 2008 - 2014 (Tabular Format)
  • Exhibit 130: PV Guidewire Market, by Type, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 131: PV Guidewire Market Growth, by Type, Japan, 2009 - 2014
  • Exhibit 132: PV Guidewire Market, by Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 133: PV Sheath Market, by Type, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 134: PV Sheath Market Growth, by Type, Japan, 2009 - 2014
  • Exhibit 135: PV Sheath Market, by Type, as a % of Total, Japan, 2008 - 2014
  • Exhibit 136: PV Diagnostic Catheter Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 137: PV Guiding Catheter Market, Japan (US$ and ¥), 2008 - 2014
  • Exhibit 138: Drivers of the PV Accessory Device Market, Japan
  • Exhibit 139: Limiters of the PV Accessory Device Market, Japan
  • Exhibit 140: Leading Competitors in the Accessory Device Market, by Type, as a % of Total, Japan, 2009
  • CHAPTER 10: PERIPHERAL VASCULAR DEVICE MARKET COMPETITIVE ANALYSIS
  • Exhibit 141: Leading Competitors in the PV Device Market, by Segment, as a % of Total, Japan, 2009
  • APPENDIX B: SUPPLEMENTAL EXHIBITS
  • Exhibit 142: PV Device Market, Japan (US$), 2008 - 2014 (Detailed Format)
  • Exhibit 143: PV Stent Market, Japan (US$), 2008 - 2014 (Detailed Format)
  • Exhibit 144: PTA Balloon Catheter Procedures, by Type, Japan, 2008 - 2014 (Detailed Format)
  • Exhibit 145: CAS Procedures and EPD Penetration, Japan, 2008 - 2014 (Detailed Format)
  • Exhibit 146: IVCF Procedures, by Device Type, as a % of Total, Japan, 2008 - 2014 (Detailed Format)
  • Exhibit 147: Aortic Stent Graft Market, by Indication, Japan (US$), 2008 - 2014 (Detailed Format)
  • Exhibit 148: Synthetic Surgical Graft Market, by Indication, Japan (US$), 2008 - 2014 (Detailed Format)
  • Exhibit 149: PV Accessory Device Market, by Type, Japan (US$), 2008 - 2014 (Detailed Format)

Press Release

JAPANESE PERIPHERAL VASCULAR STENT PROCEDURES TO EXPERIENCE 11% GROWTH THROUGH 2014

February 5th, 2010

Global Information would like to present a market research report, "Japanese Markets for Peripheral Vascular Devices 2010" by Millennium Research Group.

Indication-specific device approvals will accelerate procedure adoption. "Although the off-label use of peripheral vascular stents occurs in Japan, this is not common practice due to the strict regulatory environment, as well as the high cost associated with the use of these devices off-label," says Darren Navarro, Analyst at MRG. "Because the approval process for a device can take upwards of several years, some devices will continue to be used off-label due to the lack of approved devices for specific indications. Over the next few years, it is expected that more indication-specific stents will emerge in Japan to meet the growing demand for peripheral vascular stenting in the carotid, renal, and other vascular indications, including the lower extremities."

Back to Top